In Vitro Activities of 21 Antimicrobial Agents Alone and in Combination with Aminoglycosides or Fluoroquinolones against Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates Causing Bacteremia
被引:18
|
作者:
Cha, Min Kyeong
论文数: 0引用数: 0
h-index: 0
机构:
APFID, Seoul, South KoreaAPFID, Seoul, South Korea
Cha, Min Kyeong
[1
]
Kang, Cheol-In
论文数: 0引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South KoreaAPFID, Seoul, South Korea
Kang, Cheol-In
[2
]
Kim, So Hyun
论文数: 0引用数: 0
h-index: 0
机构:
APFID, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South KoreaAPFID, Seoul, South Korea
Kim, So Hyun
[1
,2
]
Cho, Sun Young
论文数: 0引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South KoreaAPFID, Seoul, South Korea
Cho, Sun Young
[2
]
Ha, Young Eun
论文数: 0引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South KoreaAPFID, Seoul, South Korea
Ha, Young Eun
[2
]
Wi, Yu Mi
论文数: 0引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Infect Dis, Chang Won, South KoreaAPFID, Seoul, South Korea
Wi, Yu Mi
[3
]
Chung, Doo Ryeon
论文数: 0引用数: 0
h-index: 0
机构:
APFID, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South KoreaAPFID, Seoul, South Korea
Chung, Doo Ryeon
[1
,2
]
Peck, Kyong Ran
论文数: 0引用数: 0
h-index: 0
机构:
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South KoreaAPFID, Seoul, South Korea
Peck, Kyong Ran
[2
]
Song, Jae-Hoon
论文数: 0引用数: 0
h-index: 0
机构:
APFID, Seoul, South Korea
Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South KoreaAPFID, Seoul, South Korea
Song, Jae-Hoon
[1
,2
]
机构:
[1] APFID, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Infect Dis, Chang Won, South Korea
We evaluated the in vitro activity of various antimicrobials alone and in combination against 291 extended-spectrum-beta-lactamase-producing Escherichia coli (ESBL-EC) isolates causing bacteremia in South Korean hospitals. Ceftazidime, cefepime, and piperacillin-tazobactam in combination with amikacin showed greater activity than found in combination with ciprofloxacin. In settings with a high prevalence of ESBL-producing pathogens, combination aminoglycoside antimicrobial therapy, especially with amikacin, may be considered for empirical therapy against suspected Gram-negative sepsis as a carbapenem-saving strategy.